In people with atrial fibrillation unsuitable for warfarin, apixaban reduces the risk of stroke compared with aspirin, with no difference in major bleeding.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Lopes, RD; Garcia, DA

Published Date

  • December 2011

Published In

Volume / Issue

  • 16 / 6

Start / End Page

  • 187 - 188

PubMed ID

  • 21803760

Pubmed Central ID

  • 21803760

Electronic International Standard Serial Number (EISSN)

  • 1473-6810

Digital Object Identifier (DOI)

  • 10.1136/ebm.2011.0023

Language

  • eng

Conference Location

  • England